Kancera AB

Kancera AB
Stock Exchange First North Sweden
EPS
SEK0.32
Market Cap
SEK178.92 M
Shares Outstanding
198.18 M
Public Float
-

Profile

Address
Karolinska Institutet Science Park
Solna AB 171 48
Sweden
Employees -
Website http://www.kancera.com
Updated 09/14/2018
Kancera AB engages in the research, development, and sale of drug candidate to pharmaceutical companies. Its portfolio includes Fractalkine, ROR inhibitors, HDAC6, and PFKFB3 projects. The company was founded by Hakan Mellstedt on April 28, 2010 and is headquartered in Solna, Sweden.

Financials

View All

Erik Kjellsson Nerpin
Chairman
Thomas Olin
Chief Executive Officer & Director